Thomas Vallet

8PUBLICATIONS
260CO-AUTHORS
Artificial life and complex adaptive systemsGene expression (incl. microarray and other genome-wide approaches)VirologyToxicology (incl. clinical toxicology)Agricultural molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|May 04, 2022
Identification of DAXX as a restriction factor of SARS-CoV-2 through a CRISPR/Cas9 screen.

Alice Mac Kain, Ghizlane Maarifi, Sophie-Marie Aicher

|Dec 16, 2021
A virus-derived microRNA targets immune response genes during SARS-CoV-2 infection.

Meetali Singh, Maxime Chazal, Piergiuseppe Quarato

|Jul 30, 2021
Drug-induced phospholipidosis confounds drug repurposing for SARS-CoV-2.

Tia A Tummino, Veronica V Rezelj, Benoit Fischer

|Apr 17, 2021
Defective viral genomes as therapeutic interfering particles against flavivirus infection in mammalian and mosquito hosts.

Veronica V Rezelj, Lucía Carrau, Fernando Merwaiss

|Feb 08, 2021
Defective viral genomes from chikungunya virus are broad-spectrum antivirals and prevent virus dissemination in mosquitoes.

Laura I Levi, Veronica V Rezelj, Annabelle Henrion-Lacritick

Pageof 2